The Effectiveness of Tecar Therapy in Management of Calf Muscle Strain Injuries (NCT07562360) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Effectiveness of Tecar Therapy in Management of Calf Muscle Strain Injuries
60 participantsStarted 2026-05-01
Plain-language summary
this study will be conducted to investigate the effect of TECAR Therapy on quality of landing, healing and Function in patient with Calf Muscle Strain.
Who can participate
Age range16 Years – 39 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged between 16-39 years of age.
* not having suffered leg injuries in the past 6 months.
* not having suffered a triceps sural rupture in the past two years.
* be diagnosed with latent MTPs in the gastric-soleus complex through manual therapy in the dominant side.
* Presence of Calf muscles Strain evaluated by Ultrasonography.
* Athlete willing and able to participate in an exercise program safely.
* The radiologist also assessed whether the tendon ends could be reduced in passive plantar flexion of the ankle joint with the knee extended.
* Athlete BMI from 18.5 to 24.9 kg / m2
Exclusion Criteria:
* connective tissue pathology.
* lymphatic disorders (lymphadenopathy).
* Skin injuries (open wounds, infection, psoriasis, tattoos, hematoma).
* peripheral neuropathies.
* previous fractures.
* previous lower limb surgeries (in the past 12 months).